Retraction: X-linked immunodeficient mice with no functional Bruton’s tyrosine kinase are protected from sepsis-induced multiple organ failure

Retraction: X-linked immunodeficient mice with no functional Bruton’s tyrosine kinase are protected from sepsis-induced multiple organ failure

Saved in:

Bibliographic Details
Main Author:	Frontiers Editorial Office
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2025-01-01
Series:	Frontiers in Immunology
Online Access:	https://www.frontiersin.org/articles/10.3389/fimmu.2025.1561879/full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Retraction: Bruton’s tyrosine kinase inhibition attenuates the cardiac dysfunction caused by cecal ligation and puncture in mice
by: Frontiers Editorial Office
Published: (2025-01-01)

Role of Bruton's Tyrosine Kinase in B Cell Development
by: Alex Maas, et al.
Published: (2001-01-01)

Peripheral neuropathy in the phase 3 ASPEN study of Bruton tyrosine kinase inhibitors for Waldenström macroglobulinemia
by: Benjamin M. Heyman, et al.
Published: (2025-02-01)

A review on the potential of Bruton’s tyrosine kinase (Btk) inhibitor – Ibrutinib for treatment of Multiple Myeloma (MM)
by: Sze-Ting Bong, et al.
Published: (2019-05-01)

Utility of Bruton’s Tyrosine Kinase Inhibitors in Light Chain Amyloidosis Caused by Lymphoplasmacytic Lymphoma (Waldenström’s Macroglobulinemia)
by: Maroun Bou Zerdan, et al.
Published: (2022-01-01)

Modulation of myeloid and T cells in vivo by Bruton’s tyrosine kinase inhibitor ibrutinib in patients with metastatic pancreatic ductal adenocarcinoma
by: Li Zhang, et al.
Published: (2023-01-01)

Retraction: A synthetic peptide designed to neutralize lipopolysaccharides attenuates metaflammation and diet-induced metabolic derangements in mice
by: Frontiers Editorial Office
Published: (2025-01-01)

Bruton’s tyrosine kinase inhibition re-sensitizes multidrug-resistant DLBCL tumors driven by BCL10 gain-of-function mutants to venetoclax
by: Caroline A. Coughlin, et al.
Published: (2025-02-01)

Retraction: Post COVID green intellectual capital management with the mediation of organizational learning capability
by: Frontiers Editorial Office
Published: (2025-02-01)

Retraction: Postoperative pulmonary complications in patients with transcatheter tricuspid valve implantation—implications for physiotherapists
by: Frontiers Editorial Office
Published: (2025-01-01)

Retraction: Bone age assessment based on deep convolutional features and fast extreme learning machine algorithm
by: Frontiers Editorial Office
Published: (2025-02-01)

Retraction: Impact of green financing on carbon drifts to mitigate climate change: mediating role of energy efficiency
by: Frontiers Editorial Office
Published: (2025-01-01)

Retraction: Mechanism of action of Asparagus officinalis extract against multiple myeloma using bioinformatics tools, in silico and in vitro study
by: Frontiers Editorial Office
Published: (2025-01-01)

Retraction: ZFP36 binds with PRC1 to inhibit tumor growth and increase 5-Fu chemosensitivity of hepatocellular carcinoma
by: Frontiers Editorial Office
Published: (2025-01-01)

Retraction: The two-component system CpxR/A represses the expression of Salmonella virulence genes by affecting the stability of the transcriptional regulator HilD
by: Frontiers Editorial Office
Published: (2025-02-01)

Retraction: Associations of vitamin D receptor polymorphisms with risk of Alzheimer's disease, Parkinson's disease, and mild cognitive impairment: a systematic review and meta-analysis
by: Frontiers Editorial Office
Published: (2025-01-01)

Retraction: How do renewable energy, economic growth and natural resources rent affect environmental sustainability in a globalized economy? Evidence from Colombia based on the gradual shift causality approach
by: Frontiers Editorial Office
Published: (2025-01-01)

Receptor Tyrosine Kinases and Inhibitors in Lung Cancer
by: Evan Pisick, et al.
Published: (2004-01-01)

Experimental and Density Functional Theory Characteristics of Ibrutinib, a Bruton’s Kinase Inhibitor Approved for Leukemia Treatment
by: Ali I. Ismail
Published: (2021-01-01)

Retraction: Ke et al. Resveratrol enhances chemosensitivity of renal cell carcinoma to paclitaxel. Frontiers in Bioscience (Landmark Edition). 2019; 24: 1452–1461
by: Frontiers in Bioscience-Landmark Editorial Office
Published: (2025-01-01)

USP8‐Dependent Family Tyrosine Kinase Promotes the Malignant Progression of Esophageal Squamous Cell Carcinoma by Upregulating Protein Tyrosine Kinase 2 Expression
by: Yuechang Wu, et al.
Published: (2025-01-01)

Erratum: Is global health truly global? A hashtag analysis of #GlobalHealth disparities on X
by: Frontiers Production Office
Published: (2025-02-01)

Protocol for a multicentre randomised controlled trial examining the effects of temporarily pausing Bruton tyrosine kinase inhibitor therapy to coincide with SARS-CoV-2 vaccination and its impact on immune responses in patients with chronic lymphocytic leukaemia
by: Abhishek Abhishek, et al.
Published: (2023-09-01)

Protein tyrosine kinase but not protein kinase C inhibition blocks receptor induced alveolar macrophage activation
by: K. Pollock, et al.
Published: (1993-01-01)

Baicalin and Baicalein Inhibit Src Tyrosine Kinase and Production of IL-6
by: Dubravko Jelić, et al.
Published: (2016-01-01)

Muscle-Specific Tyrosine Kinase-Associated Myasthenia Gravis: A Neuromuscular Surprise
by: Hassam Ali, et al.
Published: (2021-01-01)

In Vitro Activation and Inhibition of Recombinant EGFR Tyrosine Kinase Expressed in Escherichia coli
by: Jihene Elloumi-Mseddi, et al.
Published: (2013-01-01)

Maresin 1 Mitigates Inflammatory Response and Protects Mice from Sepsis
by: Ruidong Li, et al.
Published: (2016-01-01)

Pengaruh Likopen terhadap Kadar Soluble FMS-Like Tyrosine Kinase 1 pada Preeklamsi
by: Vaulinne Basyir, et al.
Published: (2021-02-01)

The Expression and Clinical Significance of Different Forms of Mer Receptor Tyrosine Kinase in Systemic Lupus Erythematosus
by: Huaqun Zhu, et al.
Published: (2014-01-01)

The tyrosine kinase inhibitor lenvatinib is oxidized by rat cytochromes P450 and affects their expression in rat liver
by: Indra Radek, et al.
Published: (2024-09-01)

Anti-microbial cetylpyridinium chloride suppresses mast cell function by targeting tyrosine phosphorylation of Syk kinase
by: Bright Obeng, et al.
Published: (2024-12-01)

Respiratory Failure Associated with Ascariasis in a Patient with Immunodeficiency
by: Lanocha Aleksandra, et al.
Published: (2016-01-01)

Induction of tyrosine aminotransferase in mice is inhibited by activated metabolites of ortho- aminoazotoluene
by: V. I. Kaledin, et al.
Published: (2015-07-01)

Rechallenge therapy versus tyrosine kinase inhibitor (TKI) for advanced metastatic colorectal cancer: a retrospective study
by: Chenming Liu, et al.
Published: (2025-02-01)

Functional interaction between receptor tyrosine kinase MET and ETS transcription factors promotes prostate cancer progression
by: Elisa Carouge, et al.
Published: (2025-02-01)

Patients outcomes in lung adenocarcinoma transforming to small-cell lung cancer after tyrosine kinase inhibitor therapy
by: Shuai Wang, et al.
Published: (2025-02-01)

Comparative safety profile of tyrosine kinase inhibitors in NSCLC: a network meta-analysis of hypertension and thrombotic risks
by: Mingming Tan, et al.
Published: (2025-01-01)

Remodeling of tumor microenvironments by EGFR tyrosine kinase inhibitors in EGFR-mutant non-small cell lung cancer
by: Soomin Kim, et al.
Published: (2025-02-01)

Using In Silico Methods to Identify Protein Tyrosine Kinase A (PtkA) Homolog in Non-Tuberculous Mycobacteria (NTM)
by: Swati Jaiswal, et al.
Published: (2024-11-01)